Recent Company News

• 11:11 PM ET Mar 23, 2026
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 07:29 PM ET Mar 22, 2026
  

  StreetAccount Metrics Recap - Sinopharm Group FY Earnings (HK$20.86, 0.00)

• 06:19 PM ET Mar 22, 2026
  

  Sinopharm Group reports FY net income attributable CNY7.16B vs StreetAccount CNY7.30B (HK$20.86, 0.00)

• 08:58 AM ET Mar 19, 2026
  

  OSR Holdings subsidiary Woori IO signs NDA with Sinopharm to explore China commercial opportunities ($0.43, 0.00)

• 01:49 AM ET Mar 17, 2026
  

  StreetAccount Consensus Metrics Preview - Sinopharm Group FY Earnings (HK$21.36, -0.08)

• 03:01 AM ET Feb 25, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (45 total)

• 03:12 AM ET Feb 24, 2026
  

  StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (49 total)

• 06:43 PM ET Dec 07, 2025
  

  Sinopharm Group initiated buy at Cinda Securities (5-Dec, timing uncertain) (HK$20.56, 0.00)

• 09:47 AM ET Nov 28, 2025
  

  Sinopharm Group chairman Zhao Bingxiang resigns from all positions due to work arrangement, effective today (HK$20.04, 0.00)

• 04:46 PM ET Nov 16, 2025
  

  StreetAccount Scorecard: Weekly performance of the FTSE China Index sectors (ending 14-Nov)